Saxonov, 10x Genomics CEO, sells $122k in stock

Thermo FisherLobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative

10x Genomics BlogSaxonov, 10x Genomics CEO, sells $122k in stock - Investing.com

10x Genomics Blog10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan

FierceBiotechRyghtAI launches clinical site search engine to aid drug developers, CROs with trial design

BioWorldSex differences shape gene activity across the human brain

FierceBiotechRare Disease Research, myTomorrows team up to help patients access trials

FierceBiotechAligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal

FierceBiotechPfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial

FierceBiotechJohnson & Johnson hands back failed eye disease gene therapy to MeiraGTx

FierceBiotech'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again

BioWorldFinancings for April 16, 2026

BioWorldIn the clinic for April 16, 2026